HealthEquity, Inc. (HQY)
NASDAQ: HQY · Real-Time Price · USD
100.99
-3.14 (-3.02%)
Jul 30, 2026, 4:00 PM EDT - Market closed
HealthEquity Balance Sheet
Financials in millions USD. Fiscal year is February - January.
Millions USD. Fiscal year is Feb - Jan.
Assets
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Jan '26 Jan 31, 2026 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 |
Cash & Equivalents | 265.37 | 318.93 | 295.95 | 403.98 | 254.27 | 225.41 |
Cash & Short-Term Investments | 265.37 | 318.93 | 295.95 | 403.98 | 254.27 | 225.41 |
Cash Growth | -7.82% | 7.76% | -26.74% | 58.88% | 12.80% | -31.44% |
Accounts Receivable | 122 | 123.7 | 118.01 | 104.89 | 96.84 | 87.43 |
Other Current Assets | 79.16 | 69.66 | 63.8 | 48.56 | 31.79 | 38.5 |
Total Current Assets | 466.53 | 512.28 | 477.75 | 557.44 | 382.89 | 351.34 |
Net Property, Plant & Equipment | 38.38 | 39.49 | 46.42 | 54.39 | 69.32 | 86.99 |
Other Intangible Assets | 1,073 | 1,097 | 1,205 | 835.95 | 936.36 | 973.14 |
Goodwill | 1,648 | 1,648 | 1,648 | 1,648 | 1,648 | 1,646 |
Other Long-Term Assets | 80.09 | 83.25 | 71.57 | 67.87 | 52.18 | 49.81 |
Total Assets | 3,306 | 3,380 | 3,449 | 3,164 | 3,089 | 3,107 |
Liabilities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Jan '26 Jan 31, 2026 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 |
Accounts Payable | 14.22 | 12.16 | 14.36 | 12.04 | 13.9 | 27.54 |
Accrued Expenses | 111.61 | 134.78 | 131.96 | 95.65 | 89.5 | 104.73 |
Current Portion of Long-Term Debt | - | - | - | - | 17.5 | 8.75 |
Current Portion of Leases | 9.92 | 9.91 | 10 | 9.4 | 10.16 | 12.17 |
Total Current Liabilities | 135.74 | 156.85 | 156.32 | 117.09 | 131.06 | 153.19 |
Long-Term Debt | 942.66 | 957.38 | 1,056 | 874.97 | 907.84 | 922.08 |
Long-Term Leases | 32.11 | 34.19 | 42.22 | 48.77 | 58.99 | 65.23 |
Other Long-Term Liabilities | 148.29 | 124.72 | 78.8 | 87.94 | 95.37 | 114.03 |
Total Long-Term Liabilities | 1,123 | 1,116 | 1,177 | 1,012 | 1,062 | 1,101 |
Total Liabilities | 1,259 | 1,273 | 1,334 | 1,129 | 1,193 | 1,255 |
Shareholders' Equity
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Jan '26 Jan 31, 2026 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 |
Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Additional Paid-in Capital | 1,902 | 1,917 | 1,906 | 1,829 | 1,746 | 1,677 |
Accumulated Other Comprehensive Income | -31.75 | -5.71 | - | - | - | - |
Retained Earnings | 177.2 | 195.91 | 209.27 | 205.63 | 149.92 | 176.06 |
Total Common Shareholders' Equity | 2,047 | 2,107 | 2,115 | 2,035 | 1,896 | 1,853 |
Shareholders' Equity | 2,047 | 2,107 | 2,115 | 2,035 | 1,896 | 1,853 |
Total Liabilities & Equity | 3,306 | 3,380 | 3,449 | 3,164 | 3,089 | 3,107 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Jan '26 Jan 31, 2026 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 |
Total Debt | 984.68 | 1,001 | 1,109 | 933.14 | 994.49 | 1,008 |
Net Cash (Debt) | -719.31 | -682.55 | -812.57 | -529.16 | -740.22 | -782.82 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -8.31 | -7.80 | -9.15 | -6.08 | -8.77 | -9.42 |
Book Value | 2,047 | 2,107 | 2,115 | 2,035 | 1,896 | 1,853 |
Book Value Per Share | 23.67 | 24.09 | 23.81 | 23.40 | 22.45 | 22.28 |
Tangible Book Value | -673.8 | -638.12 | -737.89 | -449.07 | -688.86 | -766.4 |
Tangible Book Value Per Share | -7.79 | -7.30 | -8.31 | -5.16 | -8.16 | -9.22 |